1st Aug 2007 13:44
Verona Pharma plc Notification of Website Address
Verona Pharma plc (AIM:VRP) confirms, for the purposes of AIM Rule 26, that its website address is www.veronapharma.com.
For further information please contact:
Professor Clive Page, Chairman 079 7150 4931
www.veronapharma.com
David Youngman , WH Ireland Limited 0161 832 2174
About Verona Pharma plc
Verona Pharma plc is an AIM-listed drug discovery company that is focused on finding new therapeutic drugs for the treatment of allergic rhinitis (hay fever) and other chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), as well as chronic inflammatory diseases. The Company is currently developing a long-acting bronchodilator/ anti-inflammatory drug (belonging to a class of drugs known as mixed phosphodiesterase (PDE) 3/4 inhibitors) that could be rapidly brought to clinical proof-of-concept for the treatment of hay fever and be subsequently developed for the treatment of asthma. Verona Pharma is also exploiting novel polysaccharides as potential anti-inflammatory drugs for the treatment of respiratory allergies, asthma and other inflammatory diseases.
For further information, visit the Verona Pharma website: www.veronapharma.com
VERONA PHARMA PLCRelated Shares:
VRP.L